Thoracoscopy Versus Fibrinolysis in Children With Empyema
1 other identifier
interventional
36
1 country
1
Brief Summary
The null hypothesis is that patients receiving either thoracoscopy or fibrinolysis for empyema recover in the same amount of time. Therefore, we will test this by randomizing the next 40 patients who consent to the study to one treatment or the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Mar 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 8, 2006
CompletedFirst Posted
Study publicly available on registry
May 9, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedMay 9, 2008
May 1, 2008
1.6 years
May 8, 2006
May 6, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of hospitalization after intervention
1 month
Secondary Outcomes (1)
Days where a maximum temperature was equal to or above 38 degrees C, days of tube drainage, doses of analgesia and days of oxygen requirement, hospital days after intervention, hospital charges after intervention and procedure charges
1 month
Study Arms (2)
1
ACTIVE COMPARATORVideo assisted thoracoscopic decortication
2
EXPERIMENTALFibrinolysis through the chest tube
Interventions
fibrinolysis through the chest tube
Eligibility Criteria
You may qualify if:
- Patients less than 18 years of age requiring an intervention for empyema by one of the following:
- Septation or loculation seen on ultrasound or computed tomography
- Many white blood cells, bacteria present, or thick viscid purulence identified on pleural tap
You may not qualify if:
- Immunodeficiency process
- Secondary diagnosis or condition that will keep them in the hospital beyond the empyema
- Existing contraindications to VATS or chest tube.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shawn D St. Peter, MD
Children's Mercy Hospital Kansas City
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 8, 2006
First Posted
May 9, 2006
Study Start
March 1, 2006
Primary Completion
October 1, 2007
Study Completion
October 1, 2007
Last Updated
May 9, 2008
Record last verified: 2008-05